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Purpose: Self-management is crucial for effective COPD management. This study aimed at 
identifying associations between self-management and sociodemographic characteristics, clini-
cal characteristics, and symptom burden in people with COPD.
Patients and methods: In this cross-sectional study with 225 participants diagnosed with 
COPD grades II–IV, multiple linear regression analysis was conducted, using sociodemographic 
and clinical characteristics and symptom burden (COPD Assessment Test) as the independent 
variables and the eight self-management domains of the Health Education Impact Questionnaire 
(heiQ) as the outcome variables.
Results: Higher symptom burden was significantly associated with worse scores in all self-
management domains (p,0.003), except for self-monitoring and insight (p=0.012). Higher 
disease severity (p=0.004) and numbers of comorbidities (p,0.001) were associated with 
more emotional distress, and women scored higher than men on positive and active engage-
ment in life (p=0.001). Higher score in pack-years smoking was associated with lower score 
in health-directed activities (p=0.006) and self-monitoring and insight (p,0.001), and par-
ticipation in organized physical training was associated with higher score in health-directed 
activities (p,0.001). The final models explained 3.7%–31.7% of variance (adjusted R2) across 
the eight heiQ scales.
Conclusion: A notable finding of this study was that higher symptom burden was associated 
with worse scores in all self-management domains, except for self-monitoring and insight. 
In addition, sex, disease severity, comorbidity, pack-years smoking, and participation in orga-
nized physical training were associated with one or two self-management domains. The study 
contributes to improved understanding of self-management in COPD. However, the explained 
variance levels indicate that more research needs to be done to uncover what else explains 
self-management domains in COPD.
Keywords: COPD, Health Education Impact Questionnaire, COPD Assessment Test, self-
management, symptoms, chronic disease
Introduction
COPD is a preventable and treatable chronic lung disease characterized by airflow 
obstruction that is not fully reversible with persistent respiratory symptoms.1,2 Even 
with optimal medical treatment, many people with COPD experience a symptom 
burden consisting of multiple symptoms (ie, dyspnea, coughing, wheezing, anxiety, 
depression, sleeplessness, and fatigue).3,4 Persons with COPD must, in addition to 
following complex medical regimes, monitor their disease, make lifestyle changes, 
manage its physical and psychosocial consequences, and decide when they need to 
seek professional care and when they can handle problems on their own.1,2,5 Con-
sequently, COPD is a disease involving extensive and complex self-management, 
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and in the past decade, self-management support has 
been described as a crucial element of effective COPD 
management.6,7
Self-management has been defined in different ways. 
Previously, self-management emphasized that patients 
follow directions given by health care professionals and meet 
expectations for compliance with prescribed therapies and 
medical treatment.8 Recent research has indicated that self-
management is a multidimensional construct that consists 
of various domains.9 Eight independent domains describing 
self-management have been identified in the widely used 
Health Education Impact Questionnaire (heiQ): 1) positive 
and active engagement in life; 2) health-directed activities; 
3) skill and technique acquisition; 4) constructive attitudes 
and approaches; 5) self-monitoring and insight; 6) health 
services navigation; 7) social integration and support; and 
8) emotional distress.9
During the past decade, various studies investigated the 
relationships between demographic and clinical character-
istics and self-management among persons with chronic 
diseases, including COPD.10–14 The findings have indicated 
that age,10,11 being female,12 educational achievement,10,12 
social support,10 and physical health12 are positively associ-
ated with self-management, whereas no associations are 
found with self-management and lung function, dyspnea, 
body mass index, and hospitalization.13 In addition, those 
with a very high symptom burden have been found to score 
significantly lower on self-management.14 These studies, 
though, have employed self-management as an umbrella 
term and did not specifically explore the different domains 
of self-management.
Some studies10–14 have examined the relationships 
between demographic and clinical characteristics, symptom 
burden, and the overall experience of self-management in 
persons with COPD. However, to date, no studies have speci-
fied different self-management domains and investigated the 
relationships among demographic and clinical characteristics, 
symptom burden, and different self-management domains in 
persons with COPD. Therefore, the purpose of the present 
study was to examine the relationships of sociodemographic 
and clinical characteristics and symptom burden with differ-
ent self-management domains in persons with COPD.
Patients and methods
Design, setting, and procedure
For this cross-sectional study (ClinicalTrials.gov identi-
fication: NCT02479841), 225 persons with COPD from 
11 municipalities on Norway’s West Coast were recruited 
from a hospital register between May 2014 and June 2015.
Patients were included if they were $18 years old, were 
able to read and speak Norwegian, registered with one or 
more International Classification of Disease codes J44-0, 
1, 8, or 9 after January 1, 2010, and diagnosed with COPD 
grades II–IV based on airflow limitation using Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) 
standards.2 Patients were excluded if they had a cognitive 
impairment, a substantial alcohol and/or drug abuse, or a 
life expectancy ,12 months. The study was performed 
according to the Declaration of Helsinki and approved by the 
Regional Committee of Medical Research Ethics (Reference 
No 2013/1741). Written, informed consent for participation 
in the study was obtained from all the participants.
Measures
sociodemographic and clinical characteristics
Age and sex were obtained from the hospital registers, 
while information on education, cohabitation (living alone), 
comorbidity, pack-years smoking, daily use of inhaled corti-
costeroids (ICS), participation in organized physical training, 
and previous participation in pulmonary rehabilitation 
programs was self-reported on questionnaires. Pack-years 
smoking was retrospectively calculated by multiplying years 
smoked by the average number of cigarettes divided by 20 
for ever-smokers.
lung function
When the participants were enrolled in the study, the 
research nurse reviewed registered spirometries in their 
medical records. If a spirometry conducted according to the 
international standards15,16 was registered 12 months before 
enrollment, data on postbronchodilator forced vital capacity 
(FVC) and forced expiratory volume in 1 second (FEV
1
) 
were obtained from the medical records. For participants 
with a spirometry more than 1 year earlier, the research 
nurse conducted a new test according to the international 
standards.15,16 Norwegian reference values were used to 
calculate the FEV
1
 percentage predicted (FEV
1
%).17 COPD 
disease severity (GOLD grade) was classified by using 
GOLD-defined criteria:2 mild (I), moderate (II), severe (III), 
or very severe (IV) COPD defined as FEV
1
/FVC,0.7, and 
FEV
1
% $80% (I), FEV
1
% =50%–79% (II), FEV
1
% =30%–49% 
(III), or FEV
1
% ,30% (IV), respectively.2
COPD assessment Test (CaT)
Symptom burden was measured with the CAT,18 a disease-
specific questionnaire designed to assess the symptom burden 
of persons with COPD. The questionnaire consists of eight 
items (ie, cough, phlegm, chest tightness, breathlessness, 
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activities, confidence, sleep, and energy) rated on a scale 
of 0–5. Total scores range from 0 to 40, with higher scores 
indicating higher symptom burden.18,19 Scores .30 indicate 
very high burden, 20–30 high burden, 10–20 medium burden, 
and ,10 low burden.20 CAT has been translated into various 
languages and shown to have satisfactory reliability and 
validity across European countries.18,19,21,22
heiQ
Different self-management domains were measured with 
the heiQ Version 2.0, a generic measurement of primarily 
personal self-management domains.9,23 The heiQ comprises 
40 items rated on a Likert scale ranging from “strongly 
disagree” (1) to “strongly agree” (4).23 The items cover eight 
independent domains: 1) positive and active engagement 
in life; 2) health-directed activities; 3) skill and technique 
acquisition; 4) constructive attitudes and approaches; 
5) self-monitoring and insight; 6) health services navigation; 
7) social integration and support; and 8) emotional distress.9,23 
Domains’ scores are calculated by adding the score of 
items within scales and diving the sum by the number of 
items in a particular scale; hence, all domain scores range 
between 1 and 4. Higher scores indicate higher levels of 
self-management ability, except for emotional distress, where 
higher scores indicate more distress. The heiQ has been 
translated into several languages, including Norwegian,23 
and shown to produce satisfactory psychometrical results 
across diverse settings.9,23–26
statistical analyses
Descriptive statistics were used to characterize the sample. 
A three-step procedure for linear regression models was 
used to assess the association between each outcome mea-
sure (see above for specification of heiQ domains) and each 
independent variable (ie, age, sex, education level, cohabi-
tation, comorbidities, disease severity, symptom burden, 
pack-years smoking, daily use of ICS, previous lung reha-
bilitation, and participation in organized physical training). 
First, the unadjusted model was fitted for each outcome 
and independent variable. Second, the fully adjusted model 
containing all the independent variables was estimated for 
each outcome. Finally, the final model for each outcome 
was defined depending on the results of the first two steps 
and clinical evaluations. The final models included signifi-
cant variables from the first steps, as well as age, sex, and 
disease severity.
Assumptions of normal distribution were evaluated by 
graphical methods, histograms, and Q–Q plots, and the sig-
nificance level was set at 0.05. To avoid multiple comparison 
effects within each final model, a Bonferroni adjustment was 
applied. Consequently, the marginal level depended on the 
number of independent variables in each final model. Data 
were analyzed by using the SPSS Version 23 (IBM Corp., 
Armonk, NY, USA).
Results
Of the 649 persons who met the inclusion criteria, 225 
persons consented to participate, generating a response rate 
of 34.7%.
Characteristics
The participants’ mean age was 69 (±8.4) years, and 61.3% 
were male. One third of the participants had primary-
school education only, 49.8% high-school education only, 
and 16.9% a university education. In addition, 31.1% 
were living alone. Regarding disease severity, 42.7% had 
GOLD grade II, 40% grade III, and 17.3% grade IV. The 
participants’ mean CAT total score was 19.1 (±7.5), and 
the mean number of comorbidities was 2.6 (±1.9). The 
mean pack-year for ever-smokers was 30.2 (±20.2). In 
addition, 89.1% of the participants used COPD medication, 
and 55.6% used ICS daily; 35.1% regularly participated 
in organized physical training, and 48.6% previously par-
ticipated in a pulmonary rehabilitation program. Among 
the self-management domains, self-monitoring and insight 
had the highest mean score, at 3.04 (±0.34), whereas skill 
and technique acquisition had the lowest mean score, at 
2.72 (±0.45). The mean score for emotional distress was 
2.34 (±0.62). Table 2 shows the characteristics of the 
participants.
associations among sociodemographic 
and clinical characteristics, symptom 
burden, and self-management domains
Table 1 shows the estimates for all the independent variables 
included in the final models. The unstandardized coef-
ficients of age, sex, disease severity, and the independent 
variables that had significant associations (p,0.05) with 
self-management domains in step 1 or 2 are presented. Higher 
COPD symptom burden was significantly associated with 
worse scores in all self-management domains (p,0.003), 
except for self-monitoring and insight (p=0.012). In addition, 
higher disease severity (p=0.004) and numbers of comorbidi-
ties (p,0.001) were associated with more emotional distress, 
and women scored higher than men on positive and active 
engagement in life (p=0.001). Higher score in pack-years 
smoking was associated with less health-directed activi-
ties (p=0.006) and self-monitoring and insight (p,0.001), 
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and participation in organized physical training was asso-
ciated with more health-directed activities (p,0.001). 
The final models explained 3.7%–31.7% of the variance 
(adjusted R2) across the eight heiQ scales. Further details of 
the first and second steps in the analysis are provided in the 
Supplementary material.
Discussion
This study aimed at identifying the associations of sociode-
mographic and clinical characteristics and symptom burden 
with self-management domains in persons with COPD. 
The most notable finding was the strong and consistent 
association between higher symptom burden and worse 
scores in all the self-management domains, except for self-
monitoring and insight. This study was the first to examine 
the associations between symptom burden and the various 
self-management domains in COPD and so has added impor-
tant knowledge to the literature.
In the present study, the participants with higher symp-
tom burden reported lower positive and active engagement 
in life and lower social integration and support. These 
domains include social interactions, motivation, and active 
engagement in life-fulfilling activities, sense of support from 
others, and social isolation due to illness.9 One possible 
explanation for these findings is the “vicious COPD circle,” 
in which COPD-related pathophysiological changes and 
respiratory symptoms result in reduced physical activity27,28 
and social engagement in life.29,30 Furthermore, the results 
showed that the participants with higher symptom burden 
reported less health-directed activities, including healthful 
behaviors aimed at disease prevention and health promotion 
(eg, walking, exercise, and relaxation).9,23 Regarding the 
relationship between symptom burden and physical activity, 
there is little evidence specific to COPD.2 However, physical 
activity prevents further advancement of the “vicious COPD 
circle,”29 and general evidence that physical activity may 
reduce symptoms, such as dyspnea and fatigue,2,31 supports 
the present findings. Taken together, these findings could 
indicate that, in persons with COPD, high symptom burden 
may influence health-directed activities, social functioning, 
and active engagement in life.
In addition, the results showed that the participants 
with a higher symptom burden reported less skill and 
technique acquisition. Special skills and techniques are 
necessary to manage medication regimes in COPD, and 
previous studies have indicated that nonadherence to medi-
cation is common.32,33 Among the many factors associated 
with nonadherence, self-management-related abilities are 
important.34,35 Medication nonadherence is associated with 
Table 2 Characteristics of the participants
n Value
agea 225 69.0 (8.4) 
sex, maleb 225 138 (61.3%)
gOlD gradeb 225
gOlD II 96 (42.7%)
gOlD III 90 (40.0%)
gOlD IV 39 (17.3%)
FeV1% predicted
a 213 45.9 (14.9)
educationb 219
Primary school 73 (33.3%)
high school 109 (49.8%)
University 37 (16.9%)
Cohabitationb,c 222 70 (31.1%)
Other chronic diseaseb 211 203 (96.2%)
Comorbiditya,d 210 2.6 (1.9)
Years diagnosed with COPD 177 8.5 (5.9)
BMIa 213 26.3 (5.8)
Current smokerb 219 51 (23.3%)
Previous smokerb 169 157 (69.8%)
never-smokerb 167 12 (5.3%)
Pack-years,e ever-smokersa 186 30.2 (20.2)
CaT scorea,f 215 19.12 (7.5)
mMrC scorea,g 213 1.78 (1.1)
mMrC grade 0b 32 (15.0%)
mMrC grade 1b 57 (26.8%)
mMrC grade 2b 60 (28.2%)
mMrC grade 3b 53 (24.9%)
mMrC grade 4b 11 (5.2%)
PTb,h 225 79 (35.1%)
Prb,i 216 105 (48.6%)
Daily COPD medicationb 220 196 (89.1%)
Medicationb,j 225
laBak 157 (69.8%)
laMa 153 (68.0%)
ICs 125 (55.6%)
saBak 125 (55.6%)
saMa 11 (4.9%)
lTOTb 221 6 (2.7%)
BIPaPb,l 199 6 (2.7%)
self-managementa,m
1. Positive and active engagement in life 219 2.9 (0.5)
2. health-directed behavior 218 2.7 (0.6)
3. skill and technique acquisition 217 2.7 (0.5)
4. Constructive attitudes and approaches 215 2.9 (0.5)
5. self-monitoring and insight 220 3.0 (0.3)
6. health services navigation 216 2.9 (0.5)
7. social integration and support 218 2.8 (0.5)
8. emotional distress 218 2.3 (0.6)
Notes: aMean (sD), bn (%), ccohabitation: living alone and living with someone, 
dcomorbidity: rated between 0 (no comorbidities) and 16 based on a list of common 
comorbidities, epack-years: number of cigarettes smoked per day multiplied by the 
number of years smoked and divided by 20, fCaT score (0–40), gmMrC dyspnea 
scale (0–4), hparticipation in organized PT: participation and no participation in PT, 
iprevious Pr: previous Pr and no previous Pr, juse of medication and no use of 
medication, kfive participants reported the use of more than one LABA, and five 
participants reported the use of more than one saBa, lventilator assistance by 
BIPaP, mdomains of the health education Impact Questionnaire (1–4). 
Abbreviations: BIPaP, biphasic positive airway pressure; BMI, body mass index; 
CaT, COPD assessment Test; FeV1, forced expiratory volume in 1 second; gOlD, 
global Initiative for Chronic Obstructive lung Disease; ICs, inhaled corticosteroids; 
laBa, long-acting β2-agonist; laMa, long-acting anticholinergic; lTOT, long-term 
oxygen therapy; mMRC, modified Medical Research Council; SABA, short-acting 
β2-agonist; saMa, short-acting anticholinergic; Pr, pulmonary rehabilitation; 
PT, physical training.
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more COPD symptoms;34,36 therefore, the present findings 
could be explained by increased skills and techniques, lead-
ing to improved medication adherence. It is likely that higher 
symptom burden results in intensified medical treatment,2 
which might increase the need for the acquisition of skills and 
techniques. In addition, the present research found a negative 
association between symptom burden and health services 
navigation, or the ability to interact with health care profes-
sionals and organizations and to have a good understanding 
of ways to get one’s needs met.9 High symptom burden leads 
to intensified treatment and interventions2 and greater sup-
port from the health care system,37 which might increase the 
demand for the ability to navigate health services. In addition, 
persons with better health services navigation abilities might 
receive more customized help from the health care system, 
affecting the symptom burden.
Furthermore, those with lower symptom burden had more 
constructive attitudes and approaches, which characterize the 
persons who attempt to minimize the effects of illness and do 
not let them control their lives.9 A possible explanation for 
this finding could be related to these efforts to reduce symp-
tom burden. It is also possible that a response shift, or changes 
in an individual’s internal standards and values and redefini-
tion of target constructs, could be taking place.38 Aspects of 
response shift might lead to changes both in the experience 
of symptom burden and in attitudes and approaches.
Unsurprisingly, higher symptom burden was also clearly 
associated with greater emotional distress, a negative response 
to illness as manifested in anxiety, anger, and depression.9 
This finding is supported by research showing positive 
associations of COPD-related symptoms with anxiety and 
depression in persons with COPD.39–42 The present study 
examined COPD symptom burden using the CAT,18 which 
covers symptoms related to confidence, sleep, and energy. 
This might overlap with the symptoms of emotional distress, 
anxiety, and depression. Therefore, similarities in measure-
ment items could also explain the findings.
In the present study, the participants with more severe 
disease also reported greater emotional distress. This result 
contrasts with previous studies showing no association of 
disease severity, measured by GOLD grade or FEV
1
% pre-
dicted, with anxiety and depression.42–44 The link between 
pathophysiological changes and more anxiety and depres-
sion through reduced physical activity and negative social 
consequences27–30 might explain the present results showing 
associations of disease severity and symptom burden 
with emotional distress, but further research is needed. 
In addition, the present study showed that those with more 
comorbidities reported more emotional distress. This finding 
conflicts with a recent study finding no significant association 
between high numbers of comorbidities and high levels of 
depression.45 A possible explanation of the present findings 
is that 96% of the patients in this study reported one or 
more comorbidities, and previous studies have supported 
that anxiety and depression are among the most common 
comorbidities of COPD.4,46,47
Concerning healthy activities, the participants in orga-
nized physical training reported a higher level of health-
directed activities, whereas those with more pack-years 
smoking reported a lower level of health-directed activities 
and lower self-monitoring and insight. Although the relation 
of organized physical training and general physical activity in 
people with COPD is not well established, physical training 
may support increased daily physical activity.48 Furthermore, 
the negative association between pack-years smoking and 
health-directed activities aligns with a recent study finding 
an association between high pack-years and low physical 
activity levels in those with COPD.49 The negative associa-
tion between pack-years smoking and self-monitoring and 
insight might be explained by the association of high pack-
years with increased respiratory symptoms50–52 and different 
comorbidities and complications.53,54 These findings may 
indicate that the overall situation for persons with COPD is 
complex to understand, monitor, and manage.
Finally, the present results showed that female par-
ticipants reported higher positive and active engagement in 
life, in line with the findings of other studies.55 It is possible 
that the higher level of experienced psychological distress 
among women with COPD than men56 might increase 
motivation to improve life circumstances. Another possible 
explanation is that women are more motivated to partici-
pate in self-management and educational programs.57,58 The 
findings, though, are inconclusive,59 and further research 
seems warranted.
Some study limitations have to be acknowledged. Symp-
tom burden, age, sex, education level, cohabitation, disease 
severity, comorbidity, pack-years smoking, daily use of ICS, 
organized physical training, and previous lung rehabilitation 
explained 3.7%–31.7% of variance in the different self-
management domains. The lowest explained variance was for 
health services navigation (3.7%), suggesting that navigation 
skills are independent of the sociodemographic, clinical, and 
other variables collected, while in contrast almost one third 
of the variance in positive and active engagement in life was 
explained by the model (31.7%). These results revealed a 
need for better understanding of self-management domains 
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in COPD and might indicate that other variables, such as 
hospitalization,11,60,61 coping,11 and social support,62 may 
account for some variance in self-management domains. 
However, the low explained variance could also be related 
to participants actually being very similar in some domains, 
generating low sample variation, or perhaps the heiQ does not 
reflect existing variability for persons with COPD. In addi-
tion, the study was mainly based on self-reported data, and 
the response rate was low. This study was part of a larger 
randomized controlled study, and those participated in this 
study agreed to participate in a self-management program 
consisting of weekly group conversations for 11 weeks. It is 
possible that some participants did not respond because they 
did not want to participate in the self-management program. 
The cross-sectional design makes it impossible to draw 
causal conclusions. However, the data suggest that almost 
all the heiQ domains would be useful to improve the well-
being of people with COPD. Furthermore, only persons with 
moderate-to-very severe COPD from specified geographical 
areas were invited to participate in the present study, and by 
including from a hospital register, the sample might be con-
sidered a convenience sample. Therefore, the findings might 
not be generalizable to all persons with COPD.
Implications for clinical practice
This study indicated important associations between symp-
tom burden and different self-management domains of 
COPD. The eight domains of the heiQ provide clear direc-
tion for self-management support curriculum that could be 
put in place to support people with COPD. Health-directed 
activities, skills and technique acquisition, and abilities to 
navigate in health services, together with positive engage-
ment, constructive attitudes, and social and emotional 
aspects, were all associated with lower symptom burden 
and might be recognized as important to alleviate symptoms 
and support self-management. Self-management support 
programs that specifically focus on each of the heiQ domains 
over time might improve, in particular, symptom burden; 
however, intervention research is required to rule out reverse 
causation.
Conclusion
The present study revealed significant associations between 
symptom burden and all the self-management domains, 
except for self-monitoring and insight. In addition, sex, 
disease severity, comorbidity, pack-years smoking, and 
participation in organized physical training were associated 
with one or two self-management domains. The low levels 
of explained variance suggest a poor ability to explain and 
indicate that more research needs to be done to uncover what 
else explains self-management domains in COPD. However, 
the knowledge produced by this study can serve as a first 
step toward improved the understanding of characteristics 
associated with the various self-management domains in per-
sons with COPD and indicates that the heiQ domains could 
provide a direction for self-management support curriculums 
to support self-management in people with COPD.
Acknowledgments
The authors thank Gunnar Egge for his contributions in 
planning the study and research assistant Mien Parlati 
for technical assistance in preparing the data for analysis. 
Western Norway Regional Health Authority has supported 
this study by a grant (No 2103/911836), and Richard H 
Osborne was funded through a National Health and Medical 
Research Council (NHMRC) Senior Research Fellowship 
(#APP1059122).
Disclosure
The authors report no conflicts of interest in this work.
References
 1. NICE. Chronic obstructive pulmonary disease in adults (update), Qual-
ity standard [QS10]. 2016. Available from: https://www.nice.org.uk/
guidance/qs10. Accessed April 2, 2016.
 2. GOLD. Global Strategy for the Diagnosis, Management and Preven-
tion of COPD, Global Initiative for Chronic Obstructive Lung Disease. 
2017. Available from: http://goldcopd.org. Accessed May 10, 2017.
 3. Joshi M, Joshi A, Bartter T. Symptom burden in chronic obstructive pul-
monary disease and cancer. Curr Opin Pulm Med. 2012;18(2):97–103.
 4. Bentsen SB, Gundersen D, Assmus J, Bringsvor H, Berland A. Multiple 
symptoms in patients with chronic obstructive pulmonary disease in 
Norway. Nurs Health Sci. 2013;15(3):292–299.
 5. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management 
approaches for people with chronic conditions: a review. Patient Educ 
Couns. 2002;48(2):177–187.
 6. Disler RT, Gallagher RD, Davidson PM. Factors influencing self-
management in chronic obstructive pulmonary disease: an integrative 
review. Int J Nurs Stud. 2012;49(2):230–242.
 7. Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour 
modification in COPD. Patient Educ Couns. 2004;52(3):271–277.
 8. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008; 
63(9):831–838.
 9. Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact 
Questionnaire (heiQ): an outcomes and evaluation measure for patient 
education and self-management interventions for people with chronic 
conditions. Patient Educ Couns. 2007;66(2):192–201.
 10. Bos-Touwen I, Schuurmans M, Monninkhof EM, et al. Patient and 
disease characteristics associated with activation for self-management 
in patients with diabetes, chronic obstructive pulmonary disease, chronic 
heart failure and chronic renal disease: a cross-sectional survey study. 
PLoS One. 2015;10(5):e0126400.
 11. Warwick M, Gallagher R, Chenoweth L, Stin-Parbury J. Self-management 
and symptom monitoring among older adults with chronic obstructive 
pulmonary disease. J Adv Nurs. 2010;66(4):784–793.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
18
4.
18
8.
10
 o
n 
05
-J
ul
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
372
Bringsvor et al
 12. Cramm JM, Nieboer AP. Self-management abilities, physical health 
and depressive symptoms among patients with cardiovascular diseases, 
chronic obstructive pulmonary disease, and diabetes. Patient Educ 
Couns. 2012;87(3):411–415.
 13. Benzo RP, Kirsch JL, Dulohery MM, Abascal-Bolado B. Emotional 
intelligence: a novel outcome associated with wellbeing and self-
management in chronic obstructive pulmonary disease. Ann Am Thorac 
Soc. 2016;13(1):10–16.
 14. Halding AG, Grov EK. Self-rated health aspects among persons liv-
ing with chronic obstructive pulmonary disease. Int J Chron Obstruct 
Pulmon Dis. 2017;12:1163–1172.
 15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirom-
etry. Eur Respir J. 2005;26(2):319–338.
 16. GOLD. Global Institute for Chronic Obstructive Lung Disease, GOLD 
Spirometry Guide. 2010. Available from: http://goldcopd.org/gold-
spirometry-guide/. Accessed April 27, 2016.
 17. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, 
Gulsvik A. Post-bronchodilator spirometry reference values in adults 
and implications for disease management. Am J Respir Crit Care Med. 
2006;173(12):1316–1325.
 18. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. 
Development and first validation of the COPD Assessment Test. 
Eur Respir J. 2009;34(3):648–654.
 19. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD 
assessment test in a cross-sectional European study. Eur Respir J. 
2011;38(1):29–35.
 20. CAT Development Steering Group. COPD Assessment Test, Healthcare 
Professional User Guide. 2016. Issue 3: Available from: http://www.
catestonline.org/. Accessed May 10, 2017.
 21. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): 
response to pulmonary rehabilitation. A multicentre, prospective study. 
Thorax. 2011;66(5):425–429.
 22. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of 
the COPD assessment test following acute exacerbation and pulmo-
nary rehabilitation. Chest. 2012;142(1):134–140.
 23. Wahl AK, Osborne RH, Langeland E, et al. Making robust deci-
sions about the impact of health education programs: psychometric 
evaluation of the Health Education Impact Questionnaire (heiQ) in 
diverse patient groups in Norway. Patient Educ Couns. 2016;99(10): 
1733–1738.
 24. Elsworth GR, Nolte S, Osborne RH. Factor structure and measurement 
invariance of the Health Education Impact Questionnaire: does the 
subjectivity of the response perspective threaten the contextual validity 
of inferences? SAGE Open Med. 2015;3:2050312115585041.
 25. Nolte S, Elsworth GR, Osborne RH. Absence of social desirability bias 
in the evaluation of chronic disease self-management interventions. 
Health Qual Life Outcomes. 2013;11(1):114.
 26. Elsworth GR, Osborne RH. Percentile ranks and benchmark estimates 
of change for the Health Education Impact Questionnaire: norma-
tive data from an Australian sample. SAGE Open Med. 2017;5: 
2050312117695716.
 27. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstruc-
tive pulmonary disease. Clin Med (Lond). 2006;6(2):190–196.
 28. Cooper CB. Airflow obstruction and exercise. Respir Med. 2009; 
103(3):325–334.
 29. Corhay JL, Dang DN, Van Cauwenberge H, Louis R. Pulmonary 
rehabilitation and COPD: providing patients a good environment 
for optimizing therapy. Int J Chron Obstruct Pulmon Dis. 2014;9: 
27–39.
 30. Troosters T, van der Molen T, Polkey M, et al. Improving physical 
activity in COPD: towards a new paradigm. Respir Res. 2013;14:115.
 31. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. 
Pulmonary rehabilitation for chronic obstructive pulmonary disease. 
Cochrane Database Syst Rev. 2015;(2):CD003793.
 32. Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to 
inhaled medications among Veterans with COPD. J Gen Intern Med. 
2012;27(11):1506–1512.
 33. Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting 
inhaled therapies among patients with chronic obstructive pulmonary 
disease (COPD). COPD. 2012;9(3):251–258.
 34. Blackstock FC, ZuWallack R, Nici L, Lareau SC. Why don’t our patients 
with chronic obstructive pulmonary disease listen to us? The enigma 
of nonadherence. Ann Am Thorac Soc. 2016;13(3):317–323.
 35. World Health Organization. Adherence to Long Term Therapies: 
Evidence for Action. Geneva: World Health Organization; 2003. 
Available from: http://www.who.int/chp/knowledge/publications/
adherence_report/en/. Accessed December 12, 2016.
 36. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled 
therapies, health outcomes and costs in patients with asthma and COPD. 
Respir Med. 2013;107(10):1481–1490.
 37. Wagg K. Unravelling self-management for COPD: what next? Chron 
Respir Dis. 2012;9(1):5–7.
 38. Sprangers MA, Schwartz CE. Integrating response shift into health-
related quality of life research: a theoretical model. Soc Sci Med. 
1999;48(11):1507–1515.
 39. Lee YS, Park S, Oh YM, et al. Chronic obstructive pulmonary disease 
assessment test can predict depression: a prospective multi-center study. 
J Korean Med Sci. 2013;28(7):1048–1054.
 40. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with 
gender, age, health-related quality of life and symptoms in primary care 
COPD patients. Fam Prac. 2007;24(3):217–223.
 41. Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health 
outcomes in COPD. Thorax. 2010;65(3):229–234.
 42. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus 
GOLD classification for explaining anxious and depressive symptoms in 
patients with COPD – a cross-sectional study. Respir Res. 2009;10:1.
 43. Kim KU, Park HK, Jung HY, et al. Association of depression with 
disease severity in patients with chronic obstructive pulmonary disease. 
Lung. 2014;192(2):243–249.
 44. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms 
and chronic obstructive pulmonary disease: effect on mortality, hospital 
readmission, symptom burden, functional status, and quality of life. 
Arch Intern Med. 2007;167(1):60–67.
 45. Martinez Rivera C, Costan Galicia J, Alcázar Navarrete B, et al. 
Factors associated with depression in COPD: a multicenter study. 
Lung. 2016;194(3):335–343.
 46. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities 
based on validated objective measurements and systemic inflammation 
in patients with chronic obstructive pulmonary disease. Am J Respir 
Crit Care Med. 2013;187(7):728–735.
 47. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression 
and anxiety in chronic heart failure and chronic obstructive pulmonary 
disease: prevalence, relevance, clinical implications and management 
principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221.
 48. Cindy Ng LW, Mackney J, Jenkins S, Hill K. Does exercise training 
change physical activity in people with COPD? A systematic review 
and meta-analysis. Chron Respir Dis. 2012;9(1):17–26.
 49. Tödt K, Skargren E, Jakobsson P, Theander K, Unosson M. Factors 
associated with low physical activity in patients with chronic obstruc-
tive pulmonary disease: a cross-sectional study. Scand J Caring Sci. 
2015;29(4):697–707.
 50. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex 
differences in lung vulnerability to tobacco smoking. Eur Respir J. 
2003;21(6):1017–1023.
 51. Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette 
smoking gives more respiratory symptoms among women than 
among men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol 
Community Health. 2000;54(12):917–922.
 52. Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratory 
symptoms, and COPD in adults aged $45 years with a smoking history. 
Int J Chron Obstruct Pulmon Dis. 2015;10:1409–1416.
 53. Taghizadeh N, Vonk JM, Boezen HM. Lifetime smoking history and 
cause-specific mortality in a cohort study with 43 years of follow-up. 
PLoS One. 2016;11(4):e0153310.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
18
4.
18
8.
10
 o
n 
05
-J
ul
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal
The International Journal of COPD is an international, peer-reviewed 
journal of therapeutics and pharmacology focusing on concise rapid 
reporting of clinical studies and reviews in COPD. Special focus is given 
to the pathophysiological processes underlying the disease, intervention 
programs, patient focused education, and self management protocols. 
This journal is indexed on PubMed Central, MedLine and CAS. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
International Journal of COPD 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
373
symptom burden and self-management in COPD
 54. Kreuz J, Skowasch D, Kamrath P, et al. Influence of smoking dosage 
and chronic obstructive lung disease on the incidence of appropriate 
therapies and mortality in patients with structural heart disease and 
an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 
2015;38(1):71–76.
 55. Nolte S, Elsworth GR, Sinclair AJ, Osborne RH. The extent and breadth 
of benefits from participating in chronic disease self-management 
courses: a national patient-reported outcomes survey. Patient Educ 
Couns. 2007;65(3):351–360.
 56. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in 
COPD patients: the roles of gender and disease severity. Respir Med. 
2006;100(10):1767–1774.
 57. Bruce B, Lorig K, Laurent D. Participation in patient self-management 
programs. Arthritis Rheum. 2007;57(5):851–854.
 58. Bode C, De Ridder DT. Investing in the future – identifying participants 
in an educational program for middle-aged and older adults. Health 
Educ Res. 2007;22(4):473–482.
 59. Dattalo M, Giovannetti ER, Scharfstein D, et al. Who participates in 
Chronic Disease Self-Management (CDSM) Programs? Differences 
between participants and non-participants in a population of multi-
morbid older adults. Med Care. 2012;50(12):1071–1075.
 60. Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C. 
Economic benefits of self-management education in COPD. Chest. 
2006;130(6):1704–1711.
 61. Kirby SE, Dennis SM, Bazeley P, Harris MF. Activating patients with 
chronic disease for self-management: comparison of self-managing 
patients with those managing by frequent readmissions to hospital. 
Aust J Prim Health. 2013;19(3):198–206.
 62. Gallant MP. The influence of social support on chronic illness 
self-management: a review and directions for research. Health Educ 
Behav. 2003;30(2):170–195.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
18
4.
18
8.
10
 o
n 
05
-J
ul
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
